OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Bryan P. Schneider, Fei Shen, Laura Gardner, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 1, pp. 43-51
Open Access | Times Cited: 88
Bryan P. Schneider, Fei Shen, Laura Gardner, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 1, pp. 43-51
Open Access | Times Cited: 88
Showing 1-25 of 88 citing articles:
Preventing and Treating Anthracycline Cardiotoxicity: New Insights
Konrad Teodor Sawicki, Valentina Sala, Lorenzo Prever, et al.
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 309-332
Closed Access | Times Cited: 131
Konrad Teodor Sawicki, Valentina Sala, Lorenzo Prever, et al.
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 309-332
Closed Access | Times Cited: 131
Breast cancer: The translation of big genomic data to cancer precision medicine
Siew‐Kee Low, Hitoshi Zembutsu, Yusuke Nakamura
Cancer Science (2017) Vol. 109, Iss. 3, pp. 497-506
Open Access | Times Cited: 116
Siew‐Kee Low, Hitoshi Zembutsu, Yusuke Nakamura
Cancer Science (2017) Vol. 109, Iss. 3, pp. 497-506
Open Access | Times Cited: 116
Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity
Volker M. Lauschke, Yitian Zhou, Magnus Ingelman‐Sundberg
Pharmacology & Therapeutics (2019) Vol. 197, pp. 122-152
Open Access | Times Cited: 113
Volker M. Lauschke, Yitian Zhou, Magnus Ingelman‐Sundberg
Pharmacology & Therapeutics (2019) Vol. 197, pp. 122-152
Open Access | Times Cited: 113
Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes
David A. Knowles, Courtney K. Burrows, John Blischak, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 107
David A. Knowles, Courtney K. Burrows, John Blischak, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 107
Clinical and genetic associations of deep learning-derived cardiac magnetic resonance-based left ventricular mass
Shaan Khurshid, Julieta Lazarte, James P. Pirruccello, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Shaan Khurshid, Julieta Lazarte, James P. Pirruccello, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes
Hananeh Fonoudi, Mariam Jouni, Romina B. Cejas, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 1, pp. 38-50
Open Access | Times Cited: 14
Hananeh Fonoudi, Mariam Jouni, Romina B. Cejas, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 1, pp. 38-50
Open Access | Times Cited: 14
Chemotherapy-Related Cardiac Dysfunction
Marijke Linschoten, Arco J. Teske, Maarten J. Cramer, et al.
Circulation Genomic and Precision Medicine (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 78
Marijke Linschoten, Arco J. Teske, Maarten J. Cramer, et al.
Circulation Genomic and Precision Medicine (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 78
Breast cancer treatment-induced cardiotoxicity
Samuel Martel, Christian Maurer, Matteo Lambertini, et al.
Expert Opinion on Drug Safety (2017) Vol. 16, Iss. 9, pp. 1021-1038
Closed Access | Times Cited: 66
Samuel Martel, Christian Maurer, Matteo Lambertini, et al.
Expert Opinion on Drug Safety (2017) Vol. 16, Iss. 9, pp. 1021-1038
Closed Access | Times Cited: 66
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors
Smita Bhatia
JACC CardioOncology (2020) Vol. 2, Iss. 4, pp. 539-552
Open Access | Times Cited: 66
Smita Bhatia
JACC CardioOncology (2020) Vol. 2, Iss. 4, pp. 539-552
Open Access | Times Cited: 66
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer (E5103)
Kathy D. Miller, Anne O’Neill, William J. Gradishar, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 25, pp. 2621-2629
Open Access | Times Cited: 62
Kathy D. Miller, Anne O’Neill, William J. Gradishar, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 25, pp. 2621-2629
Open Access | Times Cited: 62
Pharmacogenetics of Adverse Drug Reactions
Orod Osanlou, Munir Pirmohamed, Ann K. Daly
Advances in pharmacology (2018), pp. 155-190
Closed Access | Times Cited: 59
Orod Osanlou, Munir Pirmohamed, Ann K. Daly
Advances in pharmacology (2018), pp. 155-190
Closed Access | Times Cited: 59
Novel molecular mechanisms of doxorubicin cardiotoxicity: latest leading-edge advances and clinical implications
Y. Robert Li, Kassim Traore, Hong Zhu
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 5, pp. 1121-1132
Closed Access | Times Cited: 16
Y. Robert Li, Kassim Traore, Hong Zhu
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 5, pp. 1121-1132
Closed Access | Times Cited: 16
Pharmacogenetics of Chemotherapy-Induced Cardiotoxicity
Vivian Y. Chang, Jessica Wang
Current Oncology Reports (2018) Vol. 20, Iss. 7
Open Access | Times Cited: 56
Vivian Y. Chang, Jessica Wang
Current Oncology Reports (2018) Vol. 20, Iss. 7
Open Access | Times Cited: 56
Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes
Effimia Christidi, Haojun Huang, Sanam Shafaattalab, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 43
Effimia Christidi, Haojun Huang, Sanam Shafaattalab, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 43
Anthracycline Toxicity: Light at the End of the Tunnel?
Romina B. Cejas, Kateryna Petrykey, Yadav Sapkota, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 115-134
Open Access | Times Cited: 15
Romina B. Cejas, Kateryna Petrykey, Yadav Sapkota, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 115-134
Open Access | Times Cited: 15
Anthracyclines induce cardiotoxicity through a shared gene expression response signature
E. Renee Matthews, Omar D. Johnson, K Horn, et al.
PLoS Genetics (2024) Vol. 20, Iss. 2, pp. e1011164-e1011164
Open Access | Times Cited: 5
E. Renee Matthews, Omar D. Johnson, K Horn, et al.
PLoS Genetics (2024) Vol. 20, Iss. 2, pp. e1011164-e1011164
Open Access | Times Cited: 5
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy
Zeina N. Al-Mahayri, George P. Patrinos, Bassam R. Ali
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 37
Zeina N. Al-Mahayri, George P. Patrinos, Bassam R. Ali
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 37
Machine Learning Identifies Clinical and Genetic Factors Associated With Anthracycline Cardiotoxicity in Pediatric Cancer Survivors
Marie Chaix, Neha Parmar, Caroline Kinnear, et al.
JACC CardioOncology (2020) Vol. 2, Iss. 5, pp. 690-706
Open Access | Times Cited: 34
Marie Chaix, Neha Parmar, Caroline Kinnear, et al.
JACC CardioOncology (2020) Vol. 2, Iss. 5, pp. 690-706
Open Access | Times Cited: 34
Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment
Iacopo Fabiani, Michela Chianca, Carlo M. Cipolla, et al.
Nature Reviews Cardiology (2025)
Closed Access
Iacopo Fabiani, Michela Chianca, Carlo M. Cipolla, et al.
Nature Reviews Cardiology (2025)
Closed Access
Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy
Luca Fazzini, N Campana, Stefano Cossu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1286-1286
Open Access
Luca Fazzini, N Campana, Stefano Cossu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1286-1286
Open Access
Dissecting cardiovascular disease-associated noncoding genetic variants using human iPSC models
Saif Dababneh, Hosna Babini, Verónica Jiménez-Sábado, et al.
Stem Cell Reports (2025), pp. 102467-102467
Open Access
Saif Dababneh, Hosna Babini, Verónica Jiménez-Sábado, et al.
Stem Cell Reports (2025), pp. 102467-102467
Open Access
Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-5103
Bryan P. Schneider, Fei Shen, Guanglong Jiang, et al.
JCO Precision Oncology (2017), Iss. 1, pp. 1-9
Open Access | Times Cited: 35
Bryan P. Schneider, Fei Shen, Guanglong Jiang, et al.
JCO Precision Oncology (2017), Iss. 1, pp. 1-9
Open Access | Times Cited: 35
Association of GSTM1 null variant with anthracycline‐related cardiomyopathy after childhood cancer—A Children's Oncology Group ALTE03N1 report
Purnima Singh, Xuexia Wang, Lindsey Hageman, et al.
Cancer (2020) Vol. 126, Iss. 17, pp. 4051-4058
Open Access | Times Cited: 31
Purnima Singh, Xuexia Wang, Lindsey Hageman, et al.
Cancer (2020) Vol. 126, Iss. 17, pp. 4051-4058
Open Access | Times Cited: 31
RARG S427L attenuates the DNA repair response to doxorubicin in induced pluripotent stem cell-derived cardiomyocytes
Haojun Huang, Effimia Christidi, Sanam Shafaattalab, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 4, pp. 756-765
Open Access | Times Cited: 16
Haojun Huang, Effimia Christidi, Sanam Shafaattalab, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 4, pp. 756-765
Open Access | Times Cited: 16
Artificial Intelligence for Drug Toxicity and Safety
Shivanjali Joshi-Barr, Matthew E. Wampole
Springer eBooks (2024), pp. 2637-2671
Closed Access | Times Cited: 3
Shivanjali Joshi-Barr, Matthew E. Wampole
Springer eBooks (2024), pp. 2637-2671
Closed Access | Times Cited: 3
